Skip to main content
. 2021 Nov 13;13:1071–1083. doi: 10.2147/CLEP.S335133

Table 1.

Baseline Characteristics of Entire Cohort and Study Population I (Income as Exposure) Stratified by Sex

Entire Cohort Men Women
Characteristics (N = 45,874) Low (n = 8829) Middle (n = 10,450) High (n = 11,720) Low (n = 6432) Middle (n = 4810) High (n = 3540)
Days of follow-up, median (25th–75th percentile) 1237 (525–2102) 1247 (475–2162) 1256 (505–2155) 1201 (560–2008) 1272 (503–2123) 1204 (525–2075) 1276 (613–2048)
Age (years), median + SD 65.5 (12.6) 67.4 (13.7) 63.6 (12.4) 61.5 (9.7) 73.3 (12.3) 67.1 (12.8) 62.6 (10.7)
Age group (years), n (%)
 <65 years 21,068 (45.9) 3,198 (36.2) 5058 (48.4) 7453 (63.6) 1240 (19.3) 1886 (39.2) 2160 (61.0)
 65–74 years 13,041 (28.4) 2493 (28.2) 3281 (31.4) 3178 (27.1) 1754 (27.3) 1435 (29.8) 887 (25.1)
 ≥75 years 11,765 (25.6) 3138 (35.5) 2111 (20.2) 1089 (9.3) 3.438 (53.5) 1489 (31.0) 493 (13.9)
Female, n (%) 14,803 (32.3)
Ethnicity, n (%)
 Immigrants/Descendants 3540 (7.7) 1395 (15.8) 755 (7.2) 479 (4.1) 545 (8.5) 233 (4.8) 125 (3.5)
Income level, n (%)
 Low 15,261 (33.3)
 Middle 15,260 (33.3)
 High 15,260 (33.3)
 Missing 93 (0.1)
Educational level, n (%)
 Low 17,129 (37.3) 4190 (47.5) 3684 (35.3) 2155 (18.4) 4163 (64.7) 2074 (43.1) 833 (23.5)
 Middle 19,203 (41.9) 3539 (40.1) 5201 (49.8) 5551 (47.4) 1551 (24.1) 1874 (39.0) 1442 (40.7)
 High 8109 (17.7) 660 (7.5) 1301 (12.4) 3844 (32.8) 318 (4.9) 746 (15.5) 1225 (34.6)
 Missing 1433 (3.1) 440 (5.0) 264 (2.5) 170 (1.5) 400 (6.2) 116 (2.4) 40 (1.1)
Civil status, n (%)
 Single living 15,210 (33.2) 3764 (42,6) 2780 (26.6) 1619 (13.8) 4202 (65.3) 2076 (43.2) 736 (20.8)
Somatic comorbidity (CCI), n (%)
 None (0 points) 3200 (7.0) 454 (5.1) 676 (6.5) 930 (7.9) 368 (5.7) 394 (8.2) 370 (10.5)
 Moderate (1–2 points) 34,899 (76.1) 6443 (73.0) 8112 (77.6) 9632 (82.2) 4425 (68.8) 3484 (72.4) 2721 (76.9)
 High (>2 points) 7775 (16.9) 1932 (21.9) 1662 (15.9) 1158 (9.9) 1639 (25.5) 932 (19.4) 449 (12.7)
Psychiatric comorbidity, n (%)
 Current (<90 days) 6530 (14.2) 1226 (13.9) 1117 (10.7) 808 (6.9) 1724 (26.8) 1138 (23.7) 504 (14.2)
 Recent (90–365 days) 2874 (6.2) 539 (6.1) 538 (5.1) 498 (4.2) 610 (9.5) 428 (8.9) 257 (7.3)
 Past (>365 days) 9049 (19.7) 1879 (21.3) 1868 (17.9) 1810 (15.4) 1531 (23.8) 1102 (22.9) 841 (23.8)
 None 27,421 (60.0) 5185 (58.7) 6927 (66.3) 8604 (73.4) 2567 (39.9) 2142 (44.5) 1938 (54.7)
Prior treatment, n (%)
 Antiplatelet 16,441 (35.8) 3186 (36.1) 3558 (34.0) 3635 (31.0) 2889 (44.9) 1934 (40.2) 1215 (34.3)
 Statin 14,572 (31.8) 3103 (35.1) 3079 (29.5) 2993 (25.5) 2725 (42.4) 1638 (34.1) 1013 (28.6)
Percutaneous coronary intervention, n (%) 19,297 (42.1) 3685 (41.7) 4811 (46.0) 5821 (49.7) 1927 (30.0) 1675 (34.8) 1339 (37.8)